Pluxee announces completion of Cobee acquisition

Udgivet den 26-09-2024  |  kl. 05:02  |  


 

Pluxee announces completion of Cobee acquisition

Paris, September 26, 2024 // Pluxee (the "Group"), a global leader in Employee Benefits and Engagement, today announces the successful completion of its acquisition of Cobee, a Spanish innovative digital player in Employee Benefits. The signing of this acquisition was announced on June 12, 2024, and, since then, Pluxee has obtained the necessary approval by the Spanish regulatory authorities.

With this acquisition, Pluxee delivers the first milestone of its targeted and disciplined M&A strategy, strenghtening its position in the Spanish growing and underpenetrated Employee Benefit market. The combination of Pluxee's and Cobee's respective talents, capabilities, and technology will create a complete, competitive, and attractive solution in Spain, Portugal, and Mexico, broadening the Group's existing benefit offering and enhancing its tech capabilities at global scale. 

Cobee serves more than 1,500 clients and 100,000 employee consumers with a broad multi-benefit offering, including over 12 products covering meal vouchers, training, health and life insurance, physical well-being and employee discounts.

The transaction is fully funded from existing financial resources, with limited impact on leverage. As such, the transaction is expected to be neutral in terms of Pluxee's Recurring EBITDA and Free cash flow in Fiscal 2025 and accretive to its Recurring EBITDA margin and Net income from Fiscal 2026.

About Pluxee

Pluxee is a global player in employee benefits and engagement that operates in 31 countries. Pluxee helps companies attract, engage, and retain talent thanks to a broad range of solutions across Meal & Food, Wellbeing, Lifestyle, Reward & Recognition, and Public Benefits. Powered by leading technology and more than 5,000 engaged team members, Pluxee acts as a trusted partner within a highly interconnected B2B2C ecosystem made up of more than 500,000 clients, 36 million consumers and 1.7 million merchants. Conducting business for more than 45 years, Pluxee is committed to creating a positive impact on local communities, supporting wellbeing at work for employees and protecting the planet.

For more information: www.pluxeegroup.com

About Cobee

Cobee is a Spanish startup supporting companies in managing employee benefits and compensation through a centralized digital platform. Its powerful SaaS tool drastically reduces administration and paperwork and improves the company's employer branding. In turn, employees can access and enjoy all benefits in the most flexible manner, in a single place and with a single card, which translates into unprecedented usage and uptake ratios.

Since its foundation in 2019 by Borja Aranguren, Ignacio Travesí and Daniel Olea, Cobee has been supported by well renowned venture capital funds through several financing rounds. It has expanded its Spanish operation to Portugal and Mexico. Today, it has over 180 employees and it serves more than 1,500 company clients with over 100,000 users.

For more information: www.cobee.io

Contacts

Media
Cecilia de Pierrebourg
+33 6 03 30 46 98
cecilia.depierrebourg@pluxeegroup.com
Analysts and Investors
Pauline Bireaud
+ 33 6 22 58 83 51
pauline.bireaud@pluxeegroup.com

Forward-looking statements

This press release contains forward-looking statements. These forward-looking statements reflect the Group's intentions, current beliefs, expectations and assumptions, including, without limitation, assumptions regarding the Group's future business strategies and the environment in which the Group operates, and involve known and unknown risks, uncertainties and other important factors beyond the Group's control, which may cause the Group's actual results, performance or achievements to be materially different from those expressed or implied by these forward-looking statements. These risks and uncertainties include those discussed in the prospectus dated January 10, 2024 which is available on the Company website (www.pluxeegroup.com) and the AFM website (www.afm.nl). Accordingly, readers of this press release are cautioned on relying on these forward-looking statements. These forward-looking statements are made as of the date of this press release and Pluxee Group expressly disclaims any obligation or undertaking to release any updates or revisions to any forward-looking statements included in this press release to reflect any change in expectations or any change in events, conditions or circumstances on which these forward-looking statements are based.

Disclaimer

This press release does not contain or constitute an offer of securities for sale or an invitation or inducement to invest in securities in France, the United States, or any other jurisdiction.

Attachment

Press release_Pluxee announces completion of Cobee acquisition

\Hugin

Udgivet af: NPinvestordk

Seneste nyheder

06:30 Kalender - mandag den 23 december
06:30 Kalender med link - mandag den 23. december
17:49 Europa/lukning: Danske fedmeaktier blødte og trak Europa i rødt
17:19 Fredagens obligationer: Renter faldt efter amerikanske inflationstal
17:18 Novo banket i bund efter skuffende data - aktionærerne tabte omkring 690 mia. kr.
17:06 Fredagens aktier: Øretæver til Novo Nordisk og Zealand Pharma giver solid C25-nedtur
15:46 USA/åbning: Eli Lilly vinder på Novos kollaps mens inflationsdata skærer lidt af dykket
15:17 Jeudan har milliarder klar til opkøb: "Øget optimisme kan give flere transaktioner i 2025"
15:15 Novo/Jyske Bank: Kursreaktion virker som overreaktion
14:29 USA/tendens: Eli Lilly vinder på Novos kollaps mens frygt for nedlukning varsler rød start
13:33 Korr: Udsalg af Novo-aktier presser kronen
13:24 Udsalg af Novo-aktier presser kronen
12:29 Sydbank-analytiker: Voldsomt kursfald afspejler skuffelsen over Cagrisema-data
12:25 Europa/aktier: Danske fedmeaktier bløder og trækker Europa i rødt
12:22 Novo smadres på børsen efter skuffende fedmestudie - aktien taber 770 mia. kr.
12:11 Novos styrtdyk trækker C25-indekset ned i sit fjerdestørste fald nogensinde
12:09 Gubra og Zealand Pharma trækkes med ned af negativt nyt til Novo Nordisk
12:05 Novo lever ikke op til egne forventninger i vigtigt studie - aktien mister 900 mia kr -NY2
11:56 Novo lever ikke op til egne forventninger i kursfølsomt studie - aktien mister 700 mia kr
11:48 Aktier/middag: Zealand Pharma bankes tocifret ned efter FDA-afvisning og trækker C25 ned